| Product NDC: | 49884-214 |
| Proprietary Name: | Alprazolam |
| Non Proprietary Name: | alprazolam |
| Active Ingredient(s): | 2 mg/1 & nbsp; alprazolam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, ORALLY DISINTEGRATING |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49884-214 |
| Labeler Name: | Par Pharmaceutical Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA078088 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090109 |
| Package NDC: | 49884-214-74 |
| Package Description: | 10 BLISTER PACK in 1 CARTON (49884-214-74) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| NDC Code | 49884-214-74 |
| Proprietary Name | Alprazolam |
| Package Description | 10 BLISTER PACK in 1 CARTON (49884-214-74) > 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK |
| Product NDC | 49884-214 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alprazolam |
| Dosage Form Name | TABLET, ORALLY DISINTEGRATING |
| Route Name | ORAL |
| Start Marketing Date | 20090109 |
| Marketing Category Name | ANDA |
| Labeler Name | Par Pharmaceutical Inc. |
| Substance Name | ALPRAZOLAM |
| Strength Number | 2 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |